Superior Court Approves $2.5 Million Risperdal Verdict

Introduction

On October 31, 2018, a unanimous three-judge panel in the Pennsylvania Superior Court upheld the $2.5 million Risperdal verdict awarded to an Alabama boy, who developed breasts due to the antipsychotic drug.

The case was the first among thousands of other product liability lawsuits filed against J&J. In August 2015, J&J appealed to overturn the verdict awarded to the plaintiff. The plaintiff was on Risperdal to treat his autism-related behavioral issues, and his parents claimed his abnormal breast growth was the result of the drug's side effect.

More than 7,000 Risperdal product liability lawsuits against J&J are filed in the Pennsylvania State Court. Two coordinated actions have been filed for Risperdal cases: one in Los Angeles Superior Court (Risperdal and Invega Product Liability Cases, JCCP 4775) and the other in Philadelphia (In Re: Risperdal Litigation, March 2010 Term, Case No. 100300296).

Comments

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

Superior Court Approves $2.5 Million Risperdal Verdict